Editor: Atta-ur-Rahman

Frontiers in Clinical Drug Research - Alzheimer Disorders

Volume 8

eBook: US $89 Special Offer (PDF + Printed Copy): US $163
Printed Copy: US $119
Library License: US $356
ISSN: 2451-8743 (Print)
ISSN: 2214-5168 (Online)
ISBN: 978-981-14-0190-9 (Print)
ISBN: 978-981-14-0189-3 (Online)
Year of Publication: 2019
DOI: 10.2174/97898114018931190801

Introduction

Frontiers in Clinical Drug Research - Alzheimer Disorders will be of particular interest to readers interested in drug therapy of this specific neurodegenerative condition and related brain disorders as the series provides relevant reviews written by experts in the field of Alzheimer’s disease research.

The eighth volume of this series features chapters covering critical discussions on new therapies for AD. The reviews in this volume include:

  • -Novel Molecular Targets of Tauopathy; Therapeutic and Diagnostic Applications
  • -The Therapy of Alzheimer’s Disease: Towards a New Generation of Drugs
  • -Could Antibiotics Be Therapeutic Agents in Alzheimer’s Disease?
  • -Use of Antipsychotics in Patients with Alzheimer’s Disease
  • -Approaches Based on Cholinergic Hypothesis and Cholinesterase Inhibitors in the Treatment of Alzheimer's Disease
  • -Potential Biological Mechanisms with Prophylactic Action in Rapid Cognitive Impairment in Late-Onset Alzheimer's Disease

Preface

- Pp. i
Atta-ur-Rahman
Download Free

List of Contributors

- Pp. ii-iii (2)
Atta-ur-Rahman
Download Free

Novel Molecular Targets of Tauopathy; Therapeutic and Diagnostic Applications

- Pp. 1-32 (32)
Yasmeen M. Taalab, Mohamed El-Gamal, Mohamed Salama
View Abstract

The Therapy of Alzheimer’s Disease: Towards a New Generation of Drugs

- Pp. 33-80 (48)
Luca Piemontese, Fulvio Loiodice, Sílvia Chaves, Maria Amelia Santos
View Abstract

Could Antibiotics Be Therapeutic Agents in Alzheimer’s Disease?

- Pp. 81-128 (48)
Oscar Gomez-Torres, Cristina Pintado-Losa, Maria Rodriguez-Perez, Emma Burgos-Ramos
View Abstract

Use of Antipsychotics in Patients with Alzheimer’s Disease

- Pp. 129-153 (25)
Haiyun Xu, Jue He, Xiaoyin Zhuang, Yuan Shao
View Abstract

Approaches Based on Cholinergic Hypothesis and Cholinesterase Inhibitors in the Treatment of Alzheimer's Disease

- Pp. 154-190 (37)
Zeynep Ozdemir, Azime-Berna Ozcelik, Mehtap Uysal
View Abstract

Potential Biological Mechanisms with Prophylactic Action in Rapid Cognitive Impairment in Late- Onset Alzheimer's Disease

- Pp. 191-261 (71)
Ileana Marinescu, Puiu Olivian Stovicek, Dragos Marinescu, Laurentiu Mogoanta
View Abstract

Subject Index

- Pp. 262-270 (9)
Atta-ur-Rahman
Download Free

RELATED BOOKS

.Frontiers in Clinical Drug Research - CNS and Neurological Disorders.
.Neurodegenerative Diseases: Multifactorial Degenerative Processes, Biomarkers and Therapeutic Approaches.
.Frontiers in Clinical Drug Research - CNS and Neurological Disorders.
.Animal Models for Neurological Disorders.
.Natural Products in Clinical Trials.
.Good Quality Practice (GQP) in Pharmaceutical Manufacturing: A Handbook.
.Natural Products in Clinical Trials.
.Advances in Physicochemical Properties of Biopolymers: Part 1.
.Traditional Medicine for Neuronal Health.
.Recent Advances in the Treatment of Neurodegenerative Disorders.
.Alzheimer
.Advances in Alzheimer Research.